Outcome of pregnancy in sickle cell anemia patients with COVID-19 infection
- PMID: 39036691
- PMCID: PMC11259333
- DOI: 10.4103/ajts.ajts_164_21
Outcome of pregnancy in sickle cell anemia patients with COVID-19 infection
Abstract
Sickle cell anemia (SCA) is a multisystem disease, associated with increased risk for infection and thromboembolic disease, and pregnancy is a stressor for patients with SCA. In general, coronavirus disease 2019 (COVID-19) infection in SCA is associated with a favorable outcome. Literature of pregnancy in SCA with COVID is scarce. We report a case series study of pregnant women with SCA, who are confirmed positive for COVID-19 from May 2020 to March 2021. These patients showed generally mild-to-moderate disease and presented predominantly with fever and painful crisis. They showed a significant drop in Hb from baseline, and they received low-molecular-weight heparin prophylaxis (LMWH) and blood transfusion. The outcome of pregnancy is satisfactory, although the mean birth weight was significantly lower than that reported from the same SCA population.
Keywords: Coronavirus disease 2019; pregnancy; severe acute respiratory syndrome coronavirus 2; sickle cell anemia.
Copyright: © 2022 Asian Journal of Transfusion Science.
Conflict of interest statement
There are no conflicts of interest.
References
-
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020;323:1239–42. - PubMed
-
- Steinberg MH. Management of sickle cell disease. N Engl J Med. 1999;340:1021–30. - PubMed
Publication types
LinkOut - more resources
Full Text Sources